Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...

A new medical large language model (LLM) achieved over 91% accuracy in identifying female participants diagnosed with major ...

A new medical large language model (LLM) achieved over 91 percent accuracy in identifying female participants diagnosed with ...

Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...

In the previous post, readers were reacquainted with the basics of major depressive disorder (MDD). Today, we will start looking at the subtypes, beginning with major depression with psychotic ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

October is National Depression Screening Month, and this series of posts will focus on identifying and understanding the palette of variation in major depressive disorder (MDD). In the United States, ...

The American College of Lifestyle Medicine, or ACLM, released a new expert consensus statement on the role of lifestyle ...

The use of 42 mg lumateperone combined with antidepressant therapy was linked to significantly reduced severity of depression and anxiety, as well as greater response and remission rates, and was ...

The consensus statement affirms that lifestyle interventions—optimal nutrition, physical activity, restorative sleep, stress management, connectedness, and avoidance of risky substances—are integral ...